Original source: https://www.investing.com/news/stock-market-news/eli-lillys-zepbound-outperformsnovo-nordisks-wegovy-in-weight-loss-trial-4037781
Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial
Tweet on Twitter
Share on Facebook
Google+
Pinterest